Edwards Lifesciences Corp Stock Fundamentals
| EW Stock | USD 69.29 1.34 1.97% |
Edwards Lifesciences Corp fundamentals help investors to digest information that contributes to Edwards Lifesciences' financial success or failures. It also enables traders to predict the movement of Edwards Stock. The fundamental analysis module provides a way to measure Edwards Lifesciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Edwards Lifesciences stock.
At this time, Edwards Lifesciences' Income Before Tax is fairly stable compared to the past year. Total Other Income Expense Net is likely to climb to about 177.9 M in 2025, whereas Interest Expense is likely to drop slightly above 11 M in 2025. Edwards | Select Account or Indicator |
Edwards Lifesciences Corp Company Operating Margin Analysis
Edwards Lifesciences' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Edwards Lifesciences Operating Margin | 0.26 % |
Most of Edwards Lifesciences' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Edwards Lifesciences Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Edwards Operating Margin Historical Pattern
Today, most investors in Edwards Lifesciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Edwards Lifesciences' growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's operating margin growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Edwards Lifesciences operating margin as a starting point in their analysis.
Edwards Lifesciences Operating Margin |
| Timeline |
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Edwards Pretax Profit Margin
Pretax Profit Margin |
|
Based on the recorded statements, Edwards Lifesciences Corp has an Operating Margin of 0.2554%. This is 100.73% lower than that of the Health Care Equipment & Supplies sector and 100.65% lower than that of the Health Care industry. The operating margin for all United States stocks is 104.64% lower than that of the firm.
Edwards Lifesciences Corp Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Edwards Lifesciences's current stock value. Our valuation model uses many indicators to compare Edwards Lifesciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Edwards Lifesciences competition to find correlations between indicators driving Edwards Lifesciences's intrinsic value. More Info.Edwards Lifesciences Corp is rated # 4 in return on equity category among its peers. It is one of the top stocks in return on asset category among its peers reporting about 0.50 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Edwards Lifesciences Corp is roughly 2.01 . At this time, Edwards Lifesciences' Return On Equity is fairly stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Edwards Lifesciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Edwards Operating Margin Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Edwards Lifesciences' direct or indirect competition against its Operating Margin to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Edwards Lifesciences could also be used in its relative valuation, which is a method of valuing Edwards Lifesciences by comparing valuation metrics of similar companies.Edwards Lifesciences is currently under evaluation in operating margin category among its peers.
Edwards Lifesciences ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Edwards Lifesciences' sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Edwards Lifesciences' managers, analysts, and investors.Environmental | Governance | Social |
Edwards Fundamentals
| Return On Equity | 0.17 | ||||
| Return On Asset | 0.0826 | ||||
| Profit Margin | 0.77 % | ||||
| Operating Margin | 0.26 % | ||||
| Current Valuation | 37 B | ||||
| Shares Outstanding | 587.9 M | ||||
| Shares Owned By Insiders | 0.91 % | ||||
| Shares Owned By Institutions | 88.93 % | ||||
| Number Of Shares Shorted | 8.49 M | ||||
| Price To Earning | 32.77 X | ||||
| Price To Book | 4.03 X | ||||
| Price To Sales | 7.34 X | ||||
| Revenue | 5.44 B | ||||
| Gross Profit | 4.32 B | ||||
| EBITDA | 1.72 B | ||||
| Net Income | 4.17 B | ||||
| Cash And Equivalents | 769 M | ||||
| Cash Per Share | 2.81 X | ||||
| Total Debt | 700 M | ||||
| Debt To Equity | 0.11 % | ||||
| Current Ratio | 3.83 X | ||||
| Book Value Per Share | 16.99 X | ||||
| Cash Flow From Operations | 542.3 M | ||||
| Short Ratio | 1.95 X | ||||
| Earnings Per Share | 2.34 X | ||||
| Price To Earnings To Growth | 5.35 X | ||||
| Target Price | 80.42 | ||||
| Number Of Employees | 15.8 K | ||||
| Beta | 1.12 | ||||
| Market Capitalization | 39.95 B | ||||
| Total Asset | 13.06 B | ||||
| Retained Earnings | 13.17 B | ||||
| Working Capital | 4.78 B | ||||
| Current Asset | 2.05 B | ||||
| Current Liabilities | 476.2 M | ||||
| Net Asset | 13.06 B |
About Edwards Lifesciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Edwards Lifesciences Corp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Edwards Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Edwards Lifesciences Corp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 53.7 M | 51 M | |
| Total Revenue | 5.4 B | 5.7 B | |
| Cost Of Revenue | 1.1 B | 718.3 M | |
| Stock Based Compensation To Revenue | 0.03 | 0.02 | |
| Sales General And Administrative To Revenue | 0.35 | 0.36 | |
| Research And Ddevelopement To Revenue | 0.19 | 0.10 | |
| Capex To Revenue | 0.05 | 0.04 | |
| Revenue Per Share | 9.10 | 9.56 | |
| Ebit Per Revenue | 0.25 | 0.16 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Edwards Stock Analysis
When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.